ARID1A mutations induce an EGFR-like gene expression signature and confer intrinsic and acquired resistance to cetuximab treatment in first line metastatic CRC (Alliance)
- Citation:
- Cancer Res vol 80 ( (16 Supplement)) LB-063-LB-063
- Meeting Instance:
- AACR 2020
- Year:
- 2020
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- 3635
- Program:
- TRP
- Primary Committee:
- Correl Sci NOS
- Sec. Committees:
- Pharmas:
- Genetech
- Grants:
- U10CA180821, U10CA180882, U10CA180888 (SWOG)
- Corr. Author:
- Authors:
- Radia M. Johnson Xueping Qu Joshua Thomas Yvonne Kschonsak Ling Huw Fang-Shu Ou Ethan Sokol Nnamdi Ihuegbu Oliver A. Zill Omar Kabbarah Anneleen Daemen Richard Bourgon Alan Venook Federico Innocenti Heinz-Josef Lenz Felipe de Sousa e Melo Carlos Bais
- Networks:
- CA011, CA824, LAPS-MN026, LAPS-NC007, LAPS-NC010
- Study
- CALGB-80405
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: